소아 메티실린내성 확생포도알균 감염증의 임상양상과 치료
Clinical Manifestation and Treatment of Methicillin-resistant Staphylococcus aureus Infections in Children
0
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
MRSA most frequently causes skin and soft tissue infections and has an increased association with invasive infections, particularly pneumonia and musculoskeletal infections. Hospital-associated (HA) MRSA strains tend to be associated with bloodstream infections, pneumonia, and surgical site infections. Different from the United States, CA-MRSA infections are not common in Korea (only 5.9%); however, there are some CA-MRSA clones that are different from HA-MRSA clones in Korea and from CA-MRSA clones in other countries. The treatment of MRSA infections should be guided by antimicrobial susceptibility testing, the site of infection, and the infection severity. Vancomycin is the treatment of choice for invasive MRSA infections. Other agents such as trimethoprim-sulfamethoxazole, clindamycin, linezolid, quinupristin-dalfopristin, and daptomycin have been used for some conditions.
Abstract
MRSA most frequently causes skin and soft tissue infections and has an increased association with invasive infections, particularly pneumonia and musculoskeletal infections. Hospital-associated (HA) MRSA strains tend to be associated with bloodstream infections, pneumonia, and surgical site infections. Different from the United States, CA-MRSA infections are not common in Korea (only 5.9%); however, there are some CA-MRSA clones that are different from HA-MRSA clones in Korea and from CA-MRSA clones in other countries. The treatment of MRSA infections should be guided by antimicrobial susceptibility testing, the site of infection, and the infection severity. Vancomycin is the treatment of choice for invasive MRSA infections. Other agents such as trimethoprim-sulfamethoxazole, clindamycin, linezolid, quinupristin-dalfopristin, and daptomycin have been used for some conditions.
참고문헌 (26)
- Benner EJ, "Growing clinical significance of methcillin-resistant Staphylococcus aureus", Lancet, 2, pp.741~744 (1968)
- Kallen AJ, "Increase in community acquired Methicillinresistant Staphylococcus aureus at a Naval Medical Center", Infect Control Hosp Epidemiol, 21, pp.223~226 (2000)
- Salmenlinna S, "Community- acquired Methicillin-resistant Staphylococcus aureus, Finland", Emerg Infect Dis, 8, pp.602~607 (2002)
- Performance standards for antimicrobial susceptibility testing. 8th information supplement, "The National Committee for Clinical Standards", The Committee, ~, pp.NCCLS document M100- S14 (2004)
- Kreiswirth B, "Evidence for a clonal origin of methicillin resistance in Staphylococcus aureus", Science, 259, pp.227~230 (1993)
- Crisostomo MI, "The evolution of methicillin resistance in Staphylococcus aureus: similarity of genetic backgrounds in historically early methicillinsusceptible and -resistant isolates and contemporary epidemic clones", Proc Natl Acad Sci USA, 통권 : 98, pp.9865~9870 (2001)
- Enright, MC, "The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA)", Proc Natl Acad Sci USA, 통권 : 99, pp.7687~7692 (2002)
- Herold BC, "Communityacquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk", JAMA, 279, pp.593~598 (1998)
- Klevens RM, "Invasive methicillin-resistant Staphylococcus aureus infections in the United States", JAMA, 298, pp.1763~1771
- Davis, KA, "Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection", Clin Infect Dis, 39, pp.776~782 (2004)
- Thompson RL, "Epidemiology of nosocomial infections caused by methicillin- resistant Staphylococcus aureus", Ann Intern Med, 97, pp.309~317 (1982)
- Wisplinghoff H, "Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study", Clin Infect Dis, 39, pp.309~317 (2004)
- Sader HS, "Antimicrobial susceptibility of gram-positive bacteria isolated from European medical centres: results of the Daptomycin Surveillance Programme (2002-2004)", Clin Microbiol Infect, 12, pp.844~852 (2006)
- Ko KS, "Genotypic diversity of methicillin-resistant Staphylococcus aureus isolates in Korean hospitals", Antimicrob Agents Chemother, 49, pp.3583~3585 (2005)
- Charlebois ED, "Origins of community strains of methicillin-resistant Staphylococcus aureus", Clin Infect Dis, 39, pp.47~54 (2004)
- Naimi TS, "Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection", JAMA, 290, pp.2976~2984 (2003)
- Salgado CD, "Community acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors", Clin Infect Dis, 36, pp.131~139 (2003)
- Jeong HY, "Antibiotic resistance of Staphylococcus aureus isolated from community in Korea", Program and abstracts of the 4th International Symposium on Antimicrobial Agents and Resistance (2003), Asian-Pacific Research Foundation for Infectious Diseases
- Ma SH, "distinct clinical and microbiological features in a Korean community", J Med Microbiol, 56, pp.866~868 (2007)
- Ko KS, "Characterization of Staphylococcus aureus nasal carriage from children attending an outpatient clinic in Seoul, Korea", Microb Drug Resist, 14, pp.37~44 (2008)
- King MD, "Emergence of community acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections", Ann Intern Med, 144, pp.309~317 (2006)
- Fridkin, SK, "Methicillinresistant Staphylococcus aureus disease in three communities", N Engl J Med, 352, pp.1436~1444 (2005)
- Gorwitz, RJ, "A review of community-associated methicillin- resistant Staphylococcus aureus skin and soft tissue infections", Pediatr Infect Dis J, 27, pp.1~7 (2008)
- Diederen BM, "The emergence of infections with community-associated methicillin resistant Staphylococcus aureus", J Infect, 52, pp.157~168 (2006)
- American Academy of Pediatrics, "Staphylococcal infections. in: Red Book: 2006 Report of the Committee on Infectious Diseases, 27th ed", pp.598~ (2006), American Academy of Pediatrics
- Karchmer, AW, "Staphylococcus aureus and vancomycin: The sequel", Ann Intern Me, 115, pp.739~741 (1991)